Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.08% is 94% below its 5-year average of 1.31%, near the low end of its 5-year range (0.01%–3.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.90% below its 12-month average of 0.09%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.08%.
DEBT TO ASSETS RATIO
0.08%
DEBT TO ASSETS RATIO AVG TTM
0.09%
DEBT TO ASSETS RATIO AVG 3Y
0.27%
DEBT TO ASSETS RATIO AVG 5Y
1.31%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.90%
CURRENT VS 3Y AVG
-71.03%
CURRENT VS 5Y AVG
-94.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-13.12%
vs the sector median at left
Praxis Precision Medicines, Inc.
Market Cap
$7.81B
Debt to Assets Ratio
0.08%
TTM Avg
0.09%
3Y Avg
0.27%
5Y Avg
1.31%
Market Cap
$7.76B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.63B
Debt to Assets Ratio
0.66%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.99B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.31B
Debt to Assets Ratio
0.81%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.81B | 0.08% | 0.09% | 0.27% | 1.31% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.76B | 0.37% | N/A | N/A | N/A |
| Cytokinetics, Incorporated (CYTK)vs › | $7.63B | 0.66% | N/A | N/A | N/A |
| TG Therapeutics, Inc. (TGTX)vs › | $7.99B | 0.46% | N/A | N/A | N/A |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 0.30% | N/A | N/A | N/A |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 0.01% | N/A | N/A | N/A |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.31B | 0.81% | N/A | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.38B | 0.04% | N/A | N/A | N/A |
| Alkermes plc (ALKS)vs › | $6.99B | 0.36% | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.67B | 0.41% | N/A | N/A | N/A |
Debt/Assets
0.1%
Debt/Equity
0.00
Current Ratio
15.73
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.08% |
| 2026-03-31 | 0.10% |
| 2025-12-31 | 0.01% |
| 2025-09-30 | 0.11% |
| 2025-06-30 | 0.17% |
| 2025-03-31 | 0.22% |
| 2024-12-31 | 0.28% |
| 2024-09-30 | 0.40% |
| 2024-06-30 | 0.44% |
| 2024-03-31 | 0.89% |
| 2023-12-31 | 2.84% |
| 2023-09-30 | 2.58% |
| 2023-06-30 | 2.25% |
| 2023-03-31 | 3.31% |
| 2022-12-31 | 3.04% |
| 2022-09-30 | 2.73% |
| 2022-06-30 | 2.19% |
| 2022-03-31 | 1.79% |
| 2021-12-31 | 1.47% |
| 2021-09-30 | 1.36% |
| 2021-06-30 | 1.28% |
| 2021-03-31 | 0.21% |
| 2020-12-31 | 0.25% |
| 2019-12-31 | 3.06% |
